FCF regularly engages in research on the pharmaceutical sector based on available data from European pharmaceutical companies.
The findings are regularly published in the
The analysis includes:
Market: Fundamental data, such as historic and projected growth rates (sales, profitability) and margins
Equity: Historic, recent and projected company valuation levels, such as trading multiples and valuation drivers
Debt: Relevant financial metrics for debt transactions, financing structures / trends and WACC development
Rating: Historic rating development, impact analysis of financial metrics and ratios on firm rating
PE: Historical deals, analysis of funding volumes and league table of the most active / financially powerful investors